Ann Åsberg

Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol

Nina Toft, Henrik Birgens, Jonas Abrahamsson et al. · European Journal Of Haematology · 2013 · 138 citations

Medicine, Oncology, Pediatrics +6

Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

Bendik Lund, Ann Åsberg, Mats Heyman et al. · Pediatric Blood & Cancer · 2010 · 127 citations

Medicine, Hematology, Oncology +17

Complying with the European Clinical Trials directive while surviving the administrative pressure – An alternative approach to toxicity registration in a cancer trial

Thomas Leth Frandsen, Mats Heyman, Jonas Abrahamsson et al. · European Journal of Cancer · 2013 · 84 citations

Pharmacy, Health Law, Oncology +13

Toxicity profile and treatment delays in <scp>NOPHO ALL</scp>2008—comparing adults and children with Philadelphia chromosome‐negative acute lymphoblastic leukemia

Nina Toft, Henrik Birgens, Jonas Abrahamsson et al. · European Journal Of Haematology · 2015 · 78 citations

Medicine, Oncology, Pediatrics +11

Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia

Thommy Svahn, Karin Mellgren, Arja Harila‐Saari et al. · Pediatric Blood & Cancer · 2016 · 50 citations

Medicine, Hematology, Pharmacology +17